JANX
Janux Therapeutics
$15.57
+$0.24 (+1.57%)Jul 27, 2026
Key metrics
The numbers that frame JANX today
- Market cap
- $949.53M
- P/E (TTM)
- -8.3
- EV / FCF
- -11.7
- Gross margin
- 100%
- EV / Sales
- 66.9
- ROIC
- -11.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $12.12
- 52wk High
- $35.34
Growth
Revenue and earnings trend for JANX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about JANX
Is Janux Therapeutics a good buy?
No. Janux Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Janux Therapeutics is selling at a very high price.
What is the market capitalization of JANX?
Janux Therapeutics's market capitalization is $949.53M.
What is the P/E ratio for JANX stock?
Janux Therapeutics's current P/E ratio is -8.3.
What is the 52-week high for JANX stock?
The 52-week high for Janux Therapeutics is $35.34. The current close of $15.57 is 55.9% below that high.
What is the 52-week low for JANX stock?
The 52-week low for Janux Therapeutics is $12.12. The current close of $15.57 is 28.5% above that low.
Does JANX stock pay dividends?
Janux Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for JANX?
Janux Therapeutics's Debt / Equity ratio is 0.02.